|
NCCN Guidelines® Insights - Merkel Cell Carcinoma, Version 1.2024 (JA copy) |
1.00 |
04/01/2026 - 12:00am to 12/31/2026 - 11:59pm |
|
NCCN Optimizing Patient Outcomes - From Mutation to Treatment: Understanding the Impact of New Targeted Therapies in Central Nervous System Cancers |
1.00 |
04/01/2026 - 12:00am to 09/11/2026 - 11:59pm |
|
NCCN Optimizing Patient Outcomes - Hitting the Right Target: Updates in Biomarker-Directed Therapy for Non-Small Cell Lung Cancer |
1.00 |
04/09/2026 - 12:00am to 10/04/2026 - 11:59pm |
|
NCCN Optimizing Patient Outcomes - Recent Advancements in Chemoradiation Strategies for Locally Advanced Cervical Cancer |
1.00 |
04/13/2026 - 12:00am to 08/30/2026 - 11:59pm |
|
NCCN 2026 Oncology Fellows Program: New Horizons in Quality Cancer Care |
5.50 |
04/20/2026 - 12:00am to 07/01/2026 - 12:00am |
|
Recorded Presentations from the NCCN 2026 Webinar Series - Optimizing Patient Outcomes: Collaborative Perspectives in Oncology |
|
04/22/2026 - 12:00am to 12/31/2027 - 11:59pm |
|
Recorded Presentation of NCCN Optimizing Patient Outcomes - In a Blink of an Eye: Updates in Frontline Therapy with Blinatumomab for Pediatric Acute... |
1.00 |
04/30/2026 - 12:00am to 04/22/2027 - 11:59pm |
|
Archived NCCN Tumor Boards: Managing Unique Toxicities and Immune-Related Adverse Effects of Treatment for Hodgkin Lymphoma |
1.00 |
05/06/2026 - 12:00am to 04/30/2027 - 12:00am |
|
NCCN Tumor Boards: New and Emerging Treatment Options for Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer |
1.00 |
05/13/2026 - 12:00am to 10/15/2026 - 12:00am |
|
Archived NCCN Tumor Boards: Optimizing Clinical Decision-Making for Resectable Non-Small Cell Lung Cancer |
1.00 |
05/15/2026 - 12:00am to 05/07/2027 - 12:00am |
Facebook
X
LinkedIn
Forward